Stock Of The Day: Vinati Organics To End Three-Year Muted Move With 50% Rally

Vinati Organics' long-term growth outlook is healthy, according to Motilal Oswal.

Vinati Organics shares rose as much as 1.72% on Tuesday, while the benchmark Nifty 50 advanced 0.95%. (Photo source: Freepik)

Shares of Vinati Organics Ltd. are poised for a 49% rally, as per Motilal Oswal Financial Services Ltd.— after a range-bound trade since 2021. The target of Rs 2,600 per share set by the brokerage will take the share to a new life high.

Shares of Vinati Organics Ltd. are poised for a 49% rally, as per Motilal Oswal Financial Services Ltd.— after a range-bound trade since 2021. The target of Rs 2,600 per share set by the brokerage will take the share to a new life high.

The long-term trend gauge of the 200-day moving average at the Rs 1,890 mark will be the key barrier to the stock reaching Motilal Oswal's target. However, the counter is also trading above the 14-day simple moving average and the 21-day exponential moving average.

The shares fell as much as 11.75% in 2025. However, saw a momentum change in the short term from Jan. 29. The stock has fallen 1.66% in the last 12 months.

The stock currently tests the resistance level of Rs 1,765. A close above could send the stock near the 200-DMA mark. On the downside, the stock sees support at Rs 1,650 level.

Vinati Organics shares rose as much as 1.72% on Tuesday, while the benchmark Nifty 50 advanced 0.95%. The relative strength index was at 61.

Ten of the 15 analysts tracking the company have a 'buy' rating, one suggests a 'hold', and four have a 'sell', according to Bloomberg data. The average of the 12-month analysts' price target implies a potential upside of 18%.

Also Read: Garden Reach Shipbuilders Stock Rises After Q3 Profit, Margin Growth

Healthy Outlook 

Vinati Organics' long-term growth outlook is healthy, according to Motilal Oswal. The brokerage maintained its 'buy' rating with a target price of Rs 2,600 per share.  

The company has three-kilo tonnes per annum capacity (combined) for MEHQ and Guaiacol, five-kilo tonnes per annum for Anisole, 30-kilo tonnes per annum for Amylene, and one-kilo tonnes per annum for four MAP. "These products will be the key growth drivers," the brokerage said.

The management has guided for a revenue CAGR of approximately 20% in the next three years, driven by new, as well as existing products (at existing prices based on volume), the brokerage said. "We expect a CAGR of 19%/23%/25% in revenue/Ebitda/profit during fiscal 2024-27."

Our long-term view remains positive for the segment, although there is a threat of Chinese supplies, Motilal Oswal pointed out.

Also Read: Stock Market Today: Sensex Rallies 1,397 Points As Tariff Fears Ease; Nifty Rises 1.62% To Recoup Two-Day Loss

lock-gif
Register for Free
to continue reading
Sign Up with Google
OR
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit.
WRITTEN BY
Sai Aravindh
Sai Aravindh is a desk writer at NDTV Profit, where he covers business and ... more
GET REGULAR UPDATES